Triazole-Based Compound as a Candidate To Develop Novel Medicines To Treat Toxoplasmosis

MLA

Jakub Pawełczyk, et al. “Triazole-Based Compound as a Candidate To Develop Novel Medicines To Treat Toxoplasmosis.” Antimicrobial Agents and Chemotherapy, vol. 58, Dec. 2014, pp. 7583–85. EBSCOhost, https://doi.org/10.1128/aac.03832-14.

APA

Jakub Pawełczyk, Katarzyna Dzitko, Lidia Węglińska, Piotr Paneth, Agata Paneth, & Tomasz Plech. (2014). Triazole-Based Compound as a Candidate To Develop Novel Medicines To Treat Toxoplasmosis. Antimicrobial Agents and Chemotherapy, 58, 7583–7585. https://doi.org/10.1128/aac.03832-14

Chicago

Jakub Pawełczyk, Katarzyna Dzitko, Lidia Węglińska, Piotr Paneth, Agata Paneth, and Tomasz Plech. 2014. “Triazole-Based Compound as a Candidate To Develop Novel Medicines To Treat Toxoplasmosis.” Antimicrobial Agents and Chemotherapy 58 (December): 7583–85. doi:10.1128/aac.03832-14.